Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults.

[1]  S. Leng,et al.  Inflammation and immune system alterations in frailty. , 2011, Clinics in geriatric medicine.

[2]  A. Falsey,et al.  Clinical and immunologic predictors of influenza illness among vaccinated older adults. , 2010, Vaccine.

[3]  M. Makary,et al.  Frailty as a predictor of surgical outcomes in older patients. , 2010, Journal of the American College of Surgeons.

[4]  F. Oftung,et al.  Standardization and validation of assays determining cellular immune responses against influenza. , 2010, Vaccine.

[5]  C. Macintyre,et al.  Incompletely matched influenza vaccine still provides protection in frail elderly. , 2010, Vaccine.

[6]  Tom Jefferson,et al.  Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.

[7]  K. Nichol Challenges in evaluating influenza vaccine effectiveness and the mortality benefits controversy. , 2009, Vaccine.

[8]  Mark A. Miller,et al.  Influenza vaccination and mortality benefits: new insights, new opportunities. , 2009, Vaccine.

[9]  L. Ferrucci,et al.  Nonlinear multisystem physiological dysregulation associated with frailty in older women: implications for etiology and treatment. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  L. Fried,et al.  Associations of neutrophil and monocyte counts with frailty in community-dwelling disabled older women: Results from the Women’s Health and Aging Studies I , 2009, Experimental Gerontology.

[11]  C. Ewen,et al.  Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. , 2009, Vaccine.

[12]  L. Ferrucci,et al.  Upregulated ex vivo expression of stress-responsive inflammatory pathway genes by LPS-challenged CD14+ monocytes in frail older adults , 2009, Mechanisms of Ageing and Development.

[13]  Edward Ehlinger,et al.  Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Nelson,et al.  Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study , 2008, The Lancet.

[15]  G. Wang,et al.  T‐Lymphocytes Expressing CC Chemokine Receptor‐5 Are Increased in Frail Older Adults , 2008, Journal of the American Geriatrics Society.

[16]  M. Basileo,et al.  Effects of Repeated Annual Influenza Vaccination on Antibody Responses against Unchanged Vaccine Antigens in Elderly Frail Institutionalized Volunteers , 2007, Gerontology.

[17]  K. Nichol,et al.  Effectiveness of influenza vaccine in the community-dwelling elderly. , 2007, The New England journal of medicine.

[18]  Cecile Viboud,et al.  Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. , 2007, The Lancet. Infectious diseases.

[19]  C. Bridges,et al.  The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.

[20]  L. Fried,et al.  Inflammation and Frailty in Older Women , 2007, Journal of the American Geriatrics Society.

[21]  C. Ewen,et al.  T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly1 , 2006, The Journal of Immunology.

[22]  B. Psaty,et al.  Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. , 2006, International journal of epidemiology.

[23]  K. Nichol,et al.  Influence of clinical outcome and outcome period definitions on estimates of absolute clinical and economic benefits of influenza vaccination in community dwelling elderly persons. , 2006, Vaccine.

[24]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[25]  Luigi Ferrucci,et al.  From bedside to bench: research agenda for frailty. , 2005, Science of aging knowledge environment : SAGE KE.

[26]  R. Bleackley,et al.  Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults. , 2005, Vaccine.

[27]  J. Margolick,et al.  T cell subsets and mortality in older community-dwelling women , 2005, Experimental Gerontology.

[28]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[29]  P. Assantachai,et al.  The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. , 2005, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[30]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[31]  S. Leng,et al.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty , 2004, Aging clinical and experimental research.

[32]  L. Ferrucci,et al.  Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[33]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[34]  L. Fried,et al.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. , 2002, Archives of internal medicine.

[35]  Kathleen Koenig,et al.  Serum Interleukin‐6 and Hemoglobin as Physiological Correlates in the Geriatric Syndrome of Frailty: A Pilot Study , 2002, Journal of the American Geriatrics Society.

[36]  E. Gardner,et al.  Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly , 2002, Experimental Gerontology.

[37]  D. Knook,et al.  Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects * , 2001, Journal of medical virology.

[38]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[39]  G. Dinant,et al.  The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .

[40]  S. Gravenstein,et al.  Efficacy of an Influenza Hemagglutinin‐Diphtheria Toxoid Conjugate Vaccine in Elderly Nursing Home Subjects During an Influenza Outbreak , 1994, Journal of the American Geriatrics Society.

[41]  W. Beyer,et al.  Antibody induction by influenza vaccines in the elderly: a review of the literature. , 1989, Vaccine.

[42]  R. Reichman,et al.  A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. , 1982, The New England journal of medicine.

[43]  Bennett Nm Diagnosis of influenza. , 1973 .

[44]  N. Bennett DIAGNOSIS OF INFLUENZA , 1973, The Medical journal of Australia.